The Drug Regulatory Authority of Pakistan (DRAP) has officially confirmed a three-month stock of essential medicines nationwide. Supported by the Pakistan Pharmaceutical Manufacturers Association (PPMA), the industry remains committed to maintaining a continuous supply of raw materials and ensuring uninterrupted availability for all citizens.
Ensuring Healthcare Stability in Pakistan Read More »
The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce that Pakistan is exploring the local production of Lenacapavir. This breakthrough, long-acting HIV prevention medicine requires only twice-yearly dosing, offering a revolutionary approach to healthcare and protection.Select 85 more words to run Humanizer.
A Giant Leap for Public Health in Pakistan Read More »
The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce a significant milestone in industry diversification. An IPO of Rs 1–2 Billion has been approved for a specialized Veterinary Subsidiary, dedicated to expanding veterinary pharmaceutical manufacturing. This move marks a strategic shift toward internal growth and investment, ensuring that Pakistan’s pharma sector remains a versatile
A New Frontier for Pakistan’s Pharma Industry Read More »
Even in 2026, COVID-19 continues to circulate in Pakistan, although its impact has evolved compared to the early pandemic years. Understanding the latest symptoms, testing options, preventive measures, and vaccination updates is crucial to stay safe and informed. This guide focuses on coronavirus symptoms in Pakistan, while also giving insights on local cases, testing, and
Coronavirus Symptoms in Pakistan — 2026 Updated Guide (What to Know Now) Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
